Deccan Health Care Limited (DECCAN.BO)
INR 30.93
(-0.9%)
INR 30.93
(-0.9%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -125.51 Million | -67.07 Million | -7.2 Million | 1.19 Million | 8.65 Million | 15.9 Million |
| Net Income | 14.92 Million | 3.64 Million | 3.22 Million | 3.89 Million | 100.87 Million | 144.8 Million |
| Depreciation & Amortization | 14.66 Million | 14.27 Million | 14.72 Million | 14.66 Million | 14.17 Million | 12.86 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -114.84 Million | -76.87 Million | -24.84 Million | -17.27 Million | -106.84 Million | -142.62 Million |
| Other non-cash items | -40.26 Million | -11 Million | 46.45 Million | 33.09 Million | 105.18 Million | 148.21 Million |
| Investing Cash Flow | -2.99 Million | 2.42 Million | -533 Thousand | -793 Thousand | -17.84 Million | -115.3 Million |
| Investments in PPE | -3.11 Million | - | -1.12 Million | -1.58 Million | -18.11 Million | -44.34 Million |
| Acquisitions | - | 2.53 Million | 494 Thousand | - | - | 35.12 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 112 Thousand | -113 Thousand | 93 Thousand | 791 Thousand | 262 Thousand | -106.08 Million |
| Financing Cash Flow | 140.43 Million | 52.3 Million | 2.19 Million | -2.62 Million | -1.13 Million | 141.03 Million |
| Debt repayment | -2.82 Million | -2.31 Million | -2.19 Million | -2.62 Million | -1.13 Million | -80.16 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 138.58 Million | 49.99 Million | - | - | - | 221.2 Million |
| Other Financing Activities | 137.61 Million | 48.9 Million | -1.51 Million | -1.08 Million | -1.83 Million | 210.84 Million |
| Accounts receivables | 21.03 Million | 7.73 Million | -3.57 Million | 80.95 Million | -11.83 Million | -17.03 Million |
| Accounts payables | -41.46 Million | 26.21 Million | 1.49 Million | -14.03 Million | -6.5 Million | 20.23 Million |
| Inventory | 10.56 Million | -2.5 Million | -15.23 Million | -70.79 Million | -58.06 Million | -124.82 Million |
| Other working capital | -146.44 Million | -108.32 Million | -7.53 Million | -13.39 Million | -30.44 Million | -20.99 Million |
| Cash at beginning of period | 14.1 Million | 26.67 Million | 32.22 Million | 34.22 Million | 44.78 Million | 3.14 Million |
| Cash at end of period | 26.02 Million | 14.33 Million | 26.67 Million | 32.22 Million | 34.22 Million | 44.78 Million |
| Capital Expenditure | -3.11 Million | - | -1.12 Million | -1.58 Million | -18.11 Million | -44.34 Million |
| Effect of forex changes on cash | - | - | - | 228 Thousand | - | - |
| Net cash flow / Change in cash | 11.92 Million | -12.33 Million | -5.55 Million | -1.99 Million | -10.55 Million | 41.63 Million |
| Free Cash Flow | -128.62 Million | -67.07 Million | -8.32 Million | -394 Thousand | -9.46 Million | -28.44 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.62 Million | 1.28 Million | 14.92 Million | 5.25 Million | 5.4 Million | 2.98 Million |
| Depreciation & Amortization | - | - | 14.66 Million | 3.99 Million | 3.16 Million | 3.93 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -154.5 Million | - | - | - |
| Other non-cash items | -3.62 Million | -1.28 Million | 37.85 Million | -5.25 Million | -5.4 Million | -2.98 Million |
| Investing Cash Flow | - | - | -3.11 Million | - | - | - |
| Investments in PPE | - | - | -3.11 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 112 Thousand | - | - | - |
| Financing Cash Flow | - | - | 141.28 Million | - | - | - |
| Debt repayment | - | - | -2.77 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 138.58 Million | - | - | - |
| Other Financing Activities | - | - | -75 Thousand | - | - | - |
| Accounts receivables | - | - | 21.03 Million | - | - | - |
| Accounts payables | - | - | -41.46 Million | - | - | - |
| Inventory | - | - | 10.56 Million | - | - | - |
| Other working capital | - | - | -144.64 Million | - | - | - |
| Cash at beginning of period | - | - | 14.33 Million | 20.01 Million | 14.61 Million | 1.75 Million |
| Cash at end of period | - | - | 26.02 Million | 5.25 Million | 20.01 Million | 2.98 Million |
| Capital Expenditure | - | - | -3.11 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 11.69 Million | -14.76 Million | 5.4 Million | 1.23 Million |
| Free Cash Flow | - | - | -129.36 Million | 5.25 Million | 5.4 Million | 2.98 Million |
BPL
000837
018880
PREMIERPOL
CAPR
HUMANSOFT